Loxo Oncology to Announce Second Quarter 2018 Financial Results
August 02 2018 - 6:45AM
Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company
developing highly selective medicines for patients with genomically
defined cancers, will announce financial results for the second
quarter ended June 30, 2018 on August 9, 2018 before the Nasdaq
market open. At 8:00 a.m. ET that day, Loxo Oncology management
will host a conference call to discuss these financial results, in
addition to recent updates on development and corporate activities.
A live webcast can be accessed under "Events
& Presentations" in the Investors & Media section of the
company's website at www.loxooncology.com. The conference call can
be accessed by dialing (877) 930-8065 (domestic) or (253) 336-8041
(international) and referring to conference ID 7291605. The webcast
will be archived and made available for replay on the company's
website beginning approximately two hours after the event.
About Loxo Oncology Loxo
Oncology is a biopharmaceutical company developing highly
selective medicines for patients with genomically defined cancers.
Our pipeline focuses on cancers that are uniquely dependent on
single gene abnormalities, such that a single drug has the
potential to treat the cancer with dramatic effect. We believe that
the most selective, purpose-built medicines have the highest
probability of maximally inhibiting the intended target, with the
intention of delivering best-in-class disease control and safety.
Our management team seeks out experienced industry partners,
world-class scientific advisors and innovative clinical-regulatory
approaches to deliver new cancer therapies to patients as quickly
and efficiently as possible. For more information, please visit the
company's website at www.loxooncology.com.
Contacts for Loxo Oncology,
Inc.Company:Lauren CohenDirector, Corporate
Communicationslcohen@loxooncology.com
Investors:Peter RahmerEndurance Advisors,
LLC415-515-9763prahmer@enduranceadvisors.com
Media:Dan Budwick1AB
Media973-271-6085dan@1abmedia.com
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Jun 2024 to Jul 2024
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Jul 2023 to Jul 2024